Region Dalarna — Clinical Trial Site

46 Registered trials

21 Currently recruiting

Organisation

Region Dalarna

Location

Falun, Sweden

Identifier

ORG-100043607

Address

Vasagatan 27, Falu Kristine, 791 37, Sweden

Departments

Barn och ungdomsmedicinsk mottagning Falu Lasarett 791 31 Falun
Children´s department
Dalecarlia Clinical Research Center, Torggatan 18, 795 30 Rättvik
Department of Hematology
Department of Medicine, Falu Hospital, 79182 Falun
Department of oncology
dept of Ob/gyn
Dept. Of Medicine, Haematology Department
Diabetes/endokrinmott, Falu Lasarett, Lasarettväg 10, 791 82 Falun
Domnarvets vårdcentral, Bergebyv 5 alt Box, 731, 781 27 Borlänge
Endocrinology/diabetes, Lasarettsvägen 10, Falu Lasarett, Falun
Falu Lasarett Hematologimottagningen, Medicinkliniken 791 82 Falun
Falu Lasarett Kardiologkliniken
Falu lasarett, Dep of Medicine, Falun
Falu Lasarett, Neurologen
Hematologi
Hematologimottagningen
Hematologimottagningen, Medicinkliniken, Falu lasarett
Hematology
Hjärtkliniken
Hudkliniken, Hudsjukvård Dalarna, Falu lasarett
Hudmottagningen, Laserettsvagen 10, Falu laserett, Falun
Kardiologi
Kardiologi Falun, Hjärtmottagning, Falu lasarett, Falun
Kardiologikliniken
Kardiologiska Kliniken
Kardiologiska kliniken, Falu lasarett, Falun
Kirurgkliniken, Falu lasarett
Kvinnokliniken, Falu lasarett, Lasarettsvägen 10, 79182 Falun
Lasarettet Falun
Lasarettet i Mora
Lung- och allergimottagning, Falu lasarett
Malungs vårdcentral, Box 64, 782 22 Malung
Medicinkliniken
Medicinkliniken Hematologimottagningen
Medicinkliniken Hematologimottagningen
N/A
Neurologmottagningen, Medicinkliniken, Falu lasarett, Falun
Norslunds vårdcentral, Kopparvägen 29, 791 42 Falun
Oncology
ÖNH-kliniken, Falu lasarett
orthopedi
Region Dalarna
Reumatolgiska kliniken
Surgical Department
Vårdcentral Vansbro, Moravägen 27, Vansbro
Vårdcentralen i Vansbro, Moravägen 27, 786 33 Vansbro
Women´s clinic, Falu hospital, 791 82 Falun

Clinical trials at this site (46)

Search interface

ALASCCA-A randomized double-blind placebo-controlled study with ASA treatment in colorectal cancer patients with mutations in the PI3K signa… Pending

2024-513778-23-00 Colon and rectal cancer tumor stage II-III, tumor with 5
SGLT2 inhibitor or metformin as standard treatment in early type 2 diabetes (SMARTEST) Pending

2024-516228-33-00 Type 2 Diabetes 6
Immediate insertion of intrauterine contraception after medical abortion Pending

2024-517082-16-01 Post medical abortion contraception 5
HiHat trial Pending

2024-519700-28-01 Patients with relapsing-remitting multiple sclerosis wi 4
An interventional, Open-label Study to Evaluate the effect of lebrikizumab on eczema and Skin Barrier Function parameters in lesional and no… Pending

2024-519811-32-00 Atopic dermatitis 6
Nordic PREdnisolon for VEstibular NeuriTis Study – an investigator-driven, triple blind, placebo controlled randomized trial Pending

2025-522399-10-00 Vestibular neuritis 5
Discontinuation Outcome in Multiple Myeloma after BCMA-CD3 treatment Recruiting

2025-524022-18-00 Multiple myeloma 4 2026-05-22
EASi-PROTKT™ - A study to test vicadrostat (BI 690517) taken together with empagliflozin in people with type 2 diabetes, high blood pressure… Recruiting

2025-521188-11-00 Type 2 diabetes 5 2025-10-15
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants with Atherosclerotic Cardiovascular Disease and … Recruiting

2024-516652-18-00 Atherosclerotic cardiovascular disease (ASCVD) and obes 5 2025-10-10
A Trial to Test How AZD0780 Affects Serious Heart, Stroke, or Vascular Problems in Patients with Heart, Stroke or Vascular Disease or at Hig… Recruiting

2025-520519-14-00 Atherosclerotic Cardiovascular Disease 5 2025-09-03
A phase 3 multicenter, randomised, prospective, open-label trial of fixed-duration (12 cycles) venetoclax/ obinutuzumab vs. fixed-duration (… Recruiting

2023-510294-34-00 small lymphocytic lymphoma (SLL) 5 2025-06-12
Phase III trial of lomustine/temozolomide (TMZ) combination therapy vs. standard TMZ therapy for newly diagnosed MGMT promoter methylated gl… Recruiting

2023-506998-35-00 Glioblastoma 5 2025-01-08
Concomitant HPV vaccination and HPV screening for rapid elimination of HPV infection and cervical cancer in Sweden Recruiting

2024-518857-41-00 HPV infection and related diseases, such as cervical in 6 2024-11-29
Assessment of short immunotherapy after radical surgery of high-risk malignant melanoma Recruiting

2023-509994-22-00 cutaneous malignant melanoma 5 2024-11-15
C1071032 - MAGNETISMM-32 A PHASE 3, OPEN-LABEL STUDY OF ELRANATAMAB MONOTHERAPY VERSUS ELOTUZUMB, POMALIDOMIDE, DEXAMETHASONE (EPd) OR POMAL… Recruiting

2023-507871-23-00 Relapsed/Refractory Multiple Myeloma 5 2024-05-27
Preeclampsia Intervention 4 Recruiting

2022-502707-29-00 Preeclampsia 5 2024-02-07
SACK Recruiting

2022-501600-10-00 Atrial fibrillation and Chronic Kidney Disease stage 5 5 2023-02-07
A Phase 3 Randomized Study Comparing Teclistamab in Combination with Daratumumab SC and Lenalidomide (Tec-DR) and Talquetamab in Combination… Recruiting

2023-503442-30-00 Multiple Myeloma 5 2022-10-14
ERIS: EGFR-Mutated Lung Cancer in Randomized Investigator-Initiated Study Recruiting

2024-518172-31-01 EGFR-mutated non-small cell lung cancer (NSCLC) not ame 5 2022-06-14
Antibiotic Impregnated Bone Graft to reduce infection in hip replacement - the ABOGRAFT trial Recruiting

2024-510921-25-00 Prosthetic Joint Infection 4 2022-03-18
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction Recruiting

2023-505438-85-00 Acute myocardial infarction (AMI) 5 2022-01-12
A randomized double-blind clinical trial comparing Hypochlorous Acid and Polyhexamethylene biguanide in treating diabetic foot ulcers Recruiting

2024-512612-22-00 Diabetic Foot Ulcer 5 2021-12-09
OPTION – OutPatienT InductiON: Labour induction in an outpatient setting - a multicentre randomized controlled trial Recruiting

2023-507164-39-00 Induction of labour 6 2021-12-01
Optimized pharmacologic treatment for broken heart (takotsubo) syndrome Recruiting

2022-501874-21-00 Takotsubo syndrome 6 2020-12-15